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Background
Mesquite is a genus of leguminous spiny trees and
shrubs abundant in the tropical and subtropical deserts.
Mesquite pollen is a potent allergen capable of inducing
allergy in susceptible individuals living remote from the
plant source. This study was conducted on 200 PAR
patients in the Suez Canal region of Egypt to determine
the prevalence of mesquite allergy and to assess the effi-
cacy of conventional ASIT in these patients.
Subjects, materials and methods
Two hundred adult PAR patients were evaluated by
allergy prick skin testing (PST) against a panel of 15 dif-
ferent aeroallergens including mesquite. Patients exhibit-
ing a positive PST response to mesquite only were
subjected to mesquite conventional subcutaneous ASIT.
All reagents were purchased from Omega Laboratories,
CANADA. Informed consents, symptom and medication
scores were obtained before and after ASIT.
Results
Eighty six patients exhibited a positive PST response to
mesquite allergen. Out of these 38 patients were positive
to mesquite allergen only. Significant improvement in
symptom and medication scores were detected in 24/38
patients 4 months after the initiation of ASIT.
Conclusions
Mesquite pollen allergy is common among Egyptian
PAR patients and ASIT with mesquite extract can
reduce the burden of the disease in these patients.
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